The U.S. Food and Drug Administration says patients who received Johnson & Johnson’s all-metal hip replacements need more frequent testing, according to Bloomberg.
In light of almost 16,800 reports of problems with all-metal hip implants since 2000, federal regulators hope that precaution will help prevent risky replacement surgery for some recipients. The FDA recommendation was part of a report advising members ...
continue reading...
According to a Wall Street Journal report, Johnson & Johnson and the U.S. Justice Department are close to settling a lengthy investigation into allegations that the company used illegal tactics in marketing its antipsychotic drug Risperdal.
The report cites unnamed sources who said the settlement would be one of the highest ever in a drug marketing case.
Federal law says drug makers can market medicines only for uses approved by the U.S. ...
continue reading...
Bloomberg reports that Johnson & Johnson has agreed to pay as much as $2.2 billion to settle federal government investigations into claims that the company illegally marketed antipsychotic drug Risperdal and other medications.
The report quotes unnamed sources as saying the settlement will include a misdemeanor plea and a criminal penalty of as much as $600 million.
But that wouldn’t be the end of Johnson & Johnson’s legal troubles. The company is ...
continue reading...
A newspaper report warns New Zealanders to brace for another round of invasive surgery after a recall of more hip implants.
According to The Dominion Post, Smith & Nephew R3 hip implants were recalled after unusually high rates of replacement surgery were required in Australia and the United Kingdom.
The report mentions a similar recall of DePuy all-metal hip implants from 2010. ...
continue reading...A past issue of the Journal of Occupational and Environmental Hygiene, chemical engineer Melvyn Kopstein warns that workplace use of petroleum-derived solvents can expose workers to benzene, a known carcinogen.
“Workers must be informed when products they use contain carcinogens such as benzene,” Kopstein writes.
He points out that federal Occupational Safety and Health Administration regulations require manufacturers of benzene-containing solvents to make that information available, in part because employers have to know when it’s necessary to take precautions such as providing ...
continue reading...Johnson & Johnson has requested that the U.S. Food and Drug Administration allow the company 120 days to take four types of vaginal mesh implants off the market, despite widespread complaints that the devices are causing severe injuries for women who receive them.
Johnson & Johnson said in a statement that the action is not technically a recall.
Vaginal mesh implants are used to treat urinary incontinence and pelvic organ prolapse, which occurs when muscles are weakened – ...
continue reading...
